Insmed Incorporated

INSM stock score: 41/100

$95.06 · +1.08% · Scored Oct 22, 2026

Technical
43
Fundamental
39
News
40

The reading

Insmed (INSM) scores 41 out of 100, which reads weak, higher than 37% of Healthcare stocks and 21% of the 4,161 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 43, fundamentals 39.

Among the fundamentals, Price Target at 100 and Revenue Growth (Quarterly) at 100 score highest, while Earnings Quality (Annual) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 16 and contrarian oscillators 72 — a split worth reading before trusting the technical total.

News sentiment is negative at 40; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 40 to 65, and it is down 15 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward INSM’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

39

Pulling it up

  • Price Target100

    Price target score compares the current stock price to analyst consensus targets.

  • Revenue Growth (Quarterly)100

    Quarterly revenue growth measures sales increase compared to the previous quarter.

  • Revenue Quality (Quarterly)100

    Revenue Quality (Quarterly) evaluates recent revenue performance using trailing 12-month data from quarterly reports.

Holding it back

  • Earnings Quality (Annual)0

    Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.

  • Price to Book Ratio0

    Price-to-Book ratio compares market value to book value.

  • Return on Equity (ROE)0

    Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity.

40 weighted scorers; 1 had no data today and are left out rather than counted as zero.

Technical · daily

24

Pulling it up

  • Candlestick Patterns100

    Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Money Flow Index (14)97

    Money Flow Index (14-period) is a volume-weighted RSI that identifies overbought and oversold conditions.

  • Bollinger Bands (50)95

    Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.

Holding it back

  • S&P 500 52W Comparison0

    S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.

  • Performance vs SPY0

    Performance versus SPY compares the stock's returns to the S&P 500 index.

  • Ichimoku Cloud0

    Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
40

Technical score by timeframe

ChartScoreWeight
Hourly491
Daily243
Weekly342
Monthly552
Quarterly642

Composite score, last 90 days

05010041Jul 25, 2026Oct 22, 2026Jul 25, 2026: 56Jul 26, 2026: 56Jul 27, 2026: 60Jul 28, 2026: 59Jul 29, 2026: 54Jul 30, 2026: 54Jul 31, 2026: 65Aug 2, 2026: 48Aug 3, 2026: 49Aug 5, 2026: 49Aug 6, 2026: 56Aug 7, 2026: 56Aug 8, 2026: 56Aug 9, 2026: 56Aug 10, 2026: 57Aug 11, 2026: 56Aug 12, 2026: 56Aug 13, 2026: 54Aug 14, 2026: 53Aug 15, 2026: 53Aug 16, 2026: 53Aug 17, 2026: 55Aug 18, 2026: 55Aug 19, 2026: 55Aug 20, 2026: 54Aug 22, 2026: 50Aug 23, 2026: 50Aug 24, 2026: 50Aug 25, 2026: 49Aug 26, 2026: 49Aug 27, 2026: 48Aug 28, 2026: 48Aug 29, 2026: 47Aug 30, 2026: 47Aug 31, 2026: 48Sep 1, 2026: 49Sep 2, 2026: 50Sep 3, 2026: 50Sep 4, 2026: 50Sep 5, 2026: 50Sep 6, 2026: 51Sep 7, 2026: 50Sep 8, 2026: 49Sep 9, 2026: 50Sep 10, 2026: 49Sep 11, 2026: 51Sep 12, 2026: 51Sep 13, 2026: 51Sep 14, 2026: 49Sep 15, 2026: 46Sep 16, 2026: 47Sep 17, 2026: 48Sep 18, 2026: 46Sep 19, 2026: 47Sep 20, 2026: 47Sep 21, 2026: 48Sep 22, 2026: 47Sep 23, 2026: 48Sep 24, 2026: 49Sep 25, 2026: 45Sep 26, 2026: 46Sep 27, 2026: 46Sep 28, 2026: 45Sep 29, 2026: 44Sep 30, 2026: 43Oct 1, 2026: 42Oct 2, 2026: 43Oct 3, 2026: 43Oct 4, 2026: 43Oct 5, 2026: 41Oct 6, 2026: 42Oct 7, 2026: 41Oct 8, 2026: 41Oct 9, 2026: 41Oct 10, 2026: 41Oct 11, 2026: 41Oct 12, 2026: 41Oct 13, 2026: 40Oct 14, 2026: 41Oct 15, 2026: 42Oct 16, 2026: 40Oct 17, 2026: 41Oct 18, 2026: 41Oct 19, 2026: 40Oct 20, 2026: 40Oct 21, 2026: 40Oct 22, 2026: 41
Show the daily numbers
DateComposite
Oct 22, 202641
Oct 21, 202640
Oct 20, 202640
Oct 19, 202640
Oct 18, 202641
Oct 17, 202641
Oct 16, 202640
Oct 15, 202642
Oct 14, 202641
Oct 13, 202640
Oct 12, 202641
Oct 11, 202641
Oct 10, 202641
Oct 9, 202641
Oct 8, 202641
Oct 7, 202641
Oct 6, 202642
Oct 5, 202641
Oct 4, 202643
Oct 3, 202643
Oct 2, 202643
Oct 1, 202642
Sep 30, 202643
Sep 29, 202644
Sep 28, 202645
Sep 27, 202646
Sep 26, 202646
Sep 25, 202645
Sep 24, 202649
Sep 23, 202648
Sep 22, 202647
Sep 21, 202648
Sep 20, 202647
Sep 19, 202647
Sep 18, 202646
Sep 17, 202648
Sep 16, 202647
Sep 15, 202646
Sep 14, 202649
Sep 13, 202651
Sep 12, 202651
Sep 11, 202651
Sep 10, 202649
Sep 9, 202650
Sep 8, 202649
Sep 7, 202650
Sep 6, 202651
Sep 5, 202650
Sep 4, 202650
Sep 3, 202650
Sep 2, 202650
Sep 1, 202649
Aug 31, 202648
Aug 30, 202647
Aug 29, 202647
Aug 28, 202648
Aug 27, 202648
Aug 26, 202649
Aug 25, 202649
Aug 24, 202650
Aug 23, 202650
Aug 22, 202650
Aug 20, 202654
Aug 19, 202655
Aug 18, 202655
Aug 17, 202655
Aug 16, 202653
Aug 15, 202653
Aug 14, 202653
Aug 13, 202654
Aug 12, 202656
Aug 11, 202656
Aug 10, 202657
Aug 9, 202656
Aug 8, 202656
Aug 7, 202656
Aug 6, 202656
Aug 5, 202649
Aug 3, 202649
Aug 2, 202648
Jul 31, 202665
Jul 30, 202654
Jul 29, 202654
Jul 28, 202659
Jul 27, 202660
Jul 26, 202656
Jul 25, 202656

Key facts

Market cap
$20.8B
Sector
Healthcare
Industry
Biotechnology
Beta
0.82
Risk grade (1–10)
6
Next earnings
Oct 29, 2026

Biotechnology peers

CompanyMarket capScore
ROIV Roivant Sciences$27.1B48
GMAB Genmab A/S$24.6B67
INCY Incyte$23.7B67
BNTX BioNTech SE$22.5B34
EXEL Exelixis$16.2B73
ASND Ascendis Pharma A/S$16.0B63

Questions

What is INSM's stock score today?

INSM scores 41/100 (Weak) as of Oct 22, 2026: technical 43, fundamental 39, and news sentiment 40, which is shown but not counted. Scores are recomputed every night.

Is INSM a buy?

The score is not a buy or sell recommendation. A 41 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the INSM score calculated?

102 weighted scorers feed it today: 40 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.